How to Develop and Implement a National Drug Policy (Second Edition)
(2001; 96 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentContributors
View the documentAbbreviations and acronyms
View the documentPreface
Open this folder and view contentsPart I: How to develop and implement a national drug policy
Close this folderPart II: Key components of a national drug policy
Close this folder4. Selection of essential drugs
View the document4.1 Essential drugs
View the document4.2 Old problems and new challenges
View the document4.3 Strategies for the selection of essential drugs
View the document4.4 Traditional and herbal medicines
Open this folder and view contents5. Affordability
Open this folder and view contents6. Drug financing
Open this folder and view contents7. Supply systems
Open this folder and view contents8. Drug regulation
Open this folder and view contents9. Rational use of drugs
Open this folder and view contents10. Research
Open this folder and view contents11. Human resources development
Open this folder and view contents12. Monitoring and evaluation
View the documentReferences
View the documentSelected WHO publications and documents of related interest
View the documentBack cover
 

4.4 Traditional and herbal medicines

In many countries, traditional medicine continues to be widely practised and its place in health care should be considered in the broader development of health policy. When developing a national drug policy, countries may wish to include traditional and herbal medicines within its scope. When introducing traditional and herbal medicines into organized health care, countries should:

• identify the health conditions that can be treated with traditional and herbal medicines;

• develop an appropriate methodology and technology for the identification, development and production of traditional and herbal medicines;19-22

• undertake studies to evaluate the quality and safety of traditional and herbal medicines, and evidence of their efficacy;23

• encourage patients, physicians, pharmacists and other health workers to be alert to adverse reactions and to notify them where possible.

Traditional and herbal medicines are usually known by local names, which often vary from country to country. There are several national and regional pharmacopoeias that include monographs on medicinal plant materials and herbal medicines.

However, there is no well-recognized convention regarding nomenclature, except official names for medicinal plant materials based on the legitimate Latin binominal name of the plant of origin (genus, species, authority and family). A series of WHO monographs on selected medicinal plants provide some information on this.24

A committee including traditional health practitioners and healers, and experts in pharmacognosy, toxicology and related fields should establish the criteria for selection of traditional and herbal medicines for health care systems. Use of he WHO guidelines for the assessment of herbal medicines is recommended.23 The drug regulatory authority should consider developing regulatory measures on traditional and herbal medicines.25

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014